Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Tenaya Therapeutics, a start-up with six academic cofounders from the Gladstone Institutes and the University of Texas Southwestern, has raised $92 million in series B financing. Tenaya is developing gene therapies for rare genetic heart conditions, as well as a gene therapy that uses a cocktail of transcription factors to convert fibroblasts into heart muscle cells after a heart attack. It is also using patient-derived cells to screen for small molecules that can treat genetic heart diseases.
This article has been sent to the following recipient: